City

Bruxelles (1)

Harrow (1)

Condition

Multiple Dose (2)

EC905 (1)

Healthy Subjects (1)

Pharmacokinetic (1)

Pharmacokinetics (1)

Phase 1 (1)

Safety (1)

Toleration (1)

Overall Status

Completed (2)

Phase

phase 1 (2)

Sponsor

Astellas Pharma Europe B.V. (1)

Pfizer (1)

Collaborator

Intervention

ec905 (1)

placebo (1)

uk-396,082 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

multiple dose

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Phase 1, Multiple Dose, Safety Trial in Bruxelles (UK-396,082, )

Completed

Phase 1
+4 more

UK-396,082
placebo

Bruxelles, Belgium

Pfizer Investigational Site

Nov 30, 2018

EC905, Pharmacokinetics, Multiple Dose Trial in Harrow (EC905)

Completed

EC905
+3 more

EC905

Harrow, United Kingdom

Parexel Early Phase Clinical Unit

May 28, 2014